Schatzman Randall C 4
4 · Bolt Biotherapeutics, Inc. · Filed Feb 28, 2023
Insider Transaction Report
Form 4
Schatzman Randall C
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-27+728,270→ 728,270 totalExercise: $1.59Exp: 2033-02-26→ Common Stock (728,270 underlying)
Footnotes (1)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023.